The clinical utility of dynamic ctDNA monitoring in inoperable localized NSCLC patients.
Yang Y, Zhang T, Wang J, Wang J, Xu Y, Zhao X, Ou Q, Shao Y, Wang X, Wu Y, Wu L, Xu X, Xu K, Zhao J, Wang L, Bi N.
Yang Y, et al.
Mol Cancer. 2022 May 19;21(1):117. doi: 10.1186/s12943-022-01590-0.
Mol Cancer. 2022.
PMID: 35590322
Free PMC article.
No abstract available.